Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa for Diabetic Retinopathy
NCT07444892Phase 2Completed
- Sponsor
- Emory University
- Start
- Apr 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levodopa in diabetic retinopathy (DR) (4 arms), sponsored by Emory University. Primary endpoint: Electroretinogram with dim flash stimuli at 6 months. Started Apr 2022; status: completed.
02
Drugs
levodopa
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT07444892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07444892.